Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03919071
Title Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

ganglioglioma

pleomorphic xanthoastrocytoma

high grade glioma

glioblastoma

malignant astrocytoma

Therapies

Dabrafenib + Trametinib

Age Groups: adult | child
Covered Countries USA

Additional content available in CKB BOOST